Amazon Scorpion Venom Molecule Kills Breast Cancer Cells
- Researchers are making strides in cancer treatment, utilizing both artificial intelligence for personalized medicine and novel molecules derived from natural sources.
- Notable progress is being reported in the fight against several aggressive cancers.
- In France, researchers at the University of toulouse Cancer Institute (IUCT-Oncopole) are leveraging artificial intelligence (AI) to analyze Magnetic Resonance Imaging (MRI) scans.
“`html
AI and Novel molecules Offer Hope in Cancer Treatment
Table of Contents
Researchers are making strides in cancer treatment, utilizing both artificial intelligence for personalized medicine and novel molecules derived from natural sources.
Advancements in Cancer Therapies
Notable progress is being reported in the fight against several aggressive cancers. A team of researchers has achieved success in treating melanoma, kidney cancer, and glioblastoma, with plans to move forward to the third phase of clinical trials. Details regarding the specific therapies and clinical trial protocols were not promptly available in the source material.
AI-Powered Personalized Medicine in France
In France, researchers at the University of toulouse Cancer Institute (IUCT-Oncopole) are leveraging artificial intelligence (AI) to analyze Magnetic Resonance Imaging (MRI) scans. The goal is to identify genetic modifications within tumors that correlate with a patient’s response to chemotherapy. This approach aims to tailor treatment plans to individual patients, maximizing effectiveness and minimizing side effects.
This research builds on the growing field of radiomics, where quantitative features are extracted from medical images to predict treatment outcomes. AI algorithms can detect subtle patterns in MRI images that might be missed by the human eye, perhaps revealing biomarkers for drug sensitivity or resistance.
Scorpion Venom as a Potential Breast Cancer Treatment
relatedly, a team at the University of Sao Paulo has identified a molecule within the venom of the Brotheas amazonicus scorpion that shows promise in treating breast cancer. Preliminary tests indicate that this molecule can induce cancer cell death. This discovery is notably relevant to HER2-positive breast cancer, one of the most aggressive forms of the disease. Euronews reports that this molecule may address therapy resistance in HER2-positive breast cancer.
Scorpion venom has been a subject of scientific interest for its complex cocktail of bioactive compounds. Researchers are increasingly exploring these compounds as potential sources of novel drugs.